Clinical Trial Update: Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot Ulcers [Phase 1]

View source ↗

Summary

Phase 1 safety study of ALLO-ASC-DFU in diabetic foot ulcers has been completed, reporting safety findings from patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• ALLO-ASC-DFU

Snippet

Sponsor: Anterogen Co., Ltd. | Conditions: Diabetic Foot Ulcer | Phase 1 | Status: COMPLETED